Ftse Mib
34.233,93
-0,41%
DAX
18.499,25
-0,54%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
63.677,07
-1,81%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX BioPharmX Corporation (BPMX) BioPharmX Corporation (BPMX) Notizie

BPMX

BioPharmX (BPMX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX
DataOraFonteTitoloSimboloCompagnia
23/03/201721:05PR Newswire (US)BioPharmX Reports Fourth Quarter and Full Year 2017 Financial ResultsAMEX:BPMXBioPharmX Corporation
21/03/201714:15PR Newswire (US)BioPharmX Invited to Present at 27th Annual Oppenheimer Healthcare ConferenceAMEX:BPMXBioPharmX Corporation
16/03/201714:15PR Newswire (US)BioPharmX to Report Fourth Quarter and Full Year Financial ResultsAMEX:BPMXBioPharmX Corporation
13/03/201714:15PR Newswire (US)BioPharmX Society of Toxicology Poster Suggests Promise of BPX-01 as Topical Acne Therapy, Highlights SafetyAMEX:BPMXBioPharmX Corporation
09/03/201715:15PR Newswire (US)BioPharmX to Present at 29th Annual ROTH ConferenceAMEX:BPMXBioPharmX Corporation
02/03/201715:15PR Newswire (US)BioPharmX Presents Poster at American Academy of Dermatology Annual Meeting Suggesting BPX-01 Safely, Efficiently Delivers Ac...AMEX:BPMXBioPharmX Corporation
22/02/201722:22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:BPMXBioPharmX Corporation
21/02/201722:18Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)AMEX:BPMXBioPharmX Corporation
21/02/201722:08Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
13/02/201723:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BPMXBioPharmX Corporation
10/02/201723:12Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:BPMXBioPharmX Corporation
26/01/201715:15PR Newswire (US)SPIE Photonics West Presentations to Show BioPharmX was First to Visualize Minocycline on the Skin Using Multiphoton Microsco...AMEX:BPMXBioPharmX Corporation
23/01/201715:15PR Newswire (US)Specialty Pharma Industry Veteran Charles Gregory Vontz Joins BioPharmX Board of DirectorsAMEX:BPMXBioPharmX Corporation
21/01/201700:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
21/01/201700:02Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BPMXBioPharmX Corporation
12/01/201715:15PR Newswire (US)BioPharmX Data Suggest Anti-Inflammatory Activity of BPX-01 Topical Minocycline GelAMEX:BPMXBioPharmX Corporation
04/01/201715:15PR Newswire (US)BioPharmX Completes Enrollment of BPX-01 Phase 2b OPAL Clinical Trial for Acne VulgarisAMEX:BPMXBioPharmX Corporation
13/12/201622:40Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BPMXBioPharmX Corporation
13/12/201622:05PR Newswire (US)BioPharmX Corporation Reports Third Quarter Financial ResultsAMEX:BPMXBioPharmX Corporation
07/12/201615:00PR Newswire (US)BioPharmX to present evidence that BPX-01 topical minocycline gel may reduce acne-associated inflammationAMEX:BPMXBioPharmX Corporation
06/12/201614:00PR Newswire (US)BioPharmX to Report Third Quarter Financial ResultsAMEX:BPMXBioPharmX Corporation
05/12/201615:00PR Newswire (US)BioPharmX Presents Research at Cell Biology 2016 Showing How Molecular Iodine Promotes Breast Health by Attacking Fibrocystic...AMEX:BPMXBioPharmX Corporation
02/12/201620:37Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
01/12/201623:00Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BPMXBioPharmX Corporation
28/11/201622:15PR Newswire (US)BioPharmX Corporation Announces Closing of a $12.5 Million Unit OfferingAMEX:BPMXBioPharmX Corporation
23/11/201612:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(1) (424b1)AMEX:BPMXBioPharmX Corporation
22/11/201614:45PR Newswire (US)BioPharmX Corporation Announces Pricing of Unit OfferingAMEX:BPMXBioPharmX Corporation
22/11/201614:00Edgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-1mef)AMEX:BPMXBioPharmX Corporation
22/11/201612:01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BPMXBioPharmX Corporation
18/11/201622:58Edgar (US Regulatory)Securities Registration Statement (s-1/a)AMEX:BPMXBioPharmX Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
FBK
Finecobank
BIT
STLAM
Stellantis NV
BIT
RACE
Ferrari NV
BIT
ENI
Eni
BIT
BC
Brunello Cucinelli
BIT
PRY
Prysmian
BIT
G
Generali
BIT
SPM
Saipem
BIT
MONC
Moncler
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network